OLIG2 Antibodies

Oligodendrocyte transcription factor 2 (OLIG2) is a protein that plays a crucial role in the development of the central nervous system (CNS). It is primarily expressed in the developing and mature central nervous system. This transcription factor is involved in the development of oligodendrocytes, which are a type of glial cell responsible for the formation of myelin, a crucial component of nerve fibers that facilitates efficient electrical conduction.

OLIG2 has been implicated in various neurological conditions, including multiple sclerosis (MS), gliomas (a type of brain tumor), and other demyelinating disorders. It is often overexpressed in gliomas and is considered a marker for certain types of glioma cells.

Antibodies against OLIG2 are commonly used in research and diagnostic settings. These antibodies help researchers study the expression pattern of Oligodendrocyte transcription factor 2 in tissues, aiding in identifying and characterizing oligodendrocytes and related cells. Antibodies against OLIG2 can also be used in immunohistochemistry and immunofluorescence techniques to detect and visualize its expression in tissue samples. Understanding its expression in tumors, such as gliomas, could have diagnostic implications.

Synonyms

Oligodendrocyte transcription factor 2, BHLHB1|OLIGO2|PRKCBP2|RACK17|bHLHe19

Research Areas

Apoptosis, Autophagy, Breast Cancer, Cancer, Cardiovascular, Cell Biology, Cellular Markers and Tags, Developmental Biology, Endocrine, Epigenetics, Gastrointestinal Tract, Hypoxia, Immuno Oncology, Immunology, Kidney, Lymphatic, Metabolism, Microbiology, Muscle, Neuroscience, Pancreatic Cancer, Prostate Cancer, Skin, Stem Cell, AKT Signaling, Angiogenesis, Articular Cartilage Extracellular Matrix, B Cell Markers, Basal Cell Marker, BBB VCAM-1 Signaling, Bladder Cancer, Cardiac Stem Cells, Colon Cancer, Colorectal Cancer, Complement System, CTLA-4 blockade immunotherapy, Cytokine Signaling, Defective Intrinsic Apoptosis, Dendritic Cell Marker, Digestion, Endothelial Cell Marker, Hematopoietic Stem Cells, Immune checkpoint, Infectious Disease, Lipid Metabolism, Lung Cancer, MAPK Signaling, Mast Cell Marker, Melanoma, Mesenchymal Stem Cell Differentiation, Mitochondria Marker, Neural Stem Cells, Neuroinflammation, Nuclear Marker, Oncology, Ovarian Cancer, PD-1 blockade immunotherapy, Signal Transduction, Stem Cell Differentiation, Transcription Factors